LUPKYNIS Drug-use Results Survey

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

September 17, 2025

Primary Completion Date

June 30, 2031

Study Completion Date

June 30, 2032

Conditions
Lupus Nephritis
Interventions
DRUG

Voclosporin (LUPKYNIS)

In general, for adults, voclosporin should be administered orally at a dose of 23.7 mg BID. The dosage may be appropriately reduced depending on the patient's condition. In principle, at the start of treatment with voclosporin, it should be used in combination with corticosteroids and mycophenolate mofetil.

Trial Locations (1)

540-0021

RECRUITING

Pharmacovigilance Department, Osaka

All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY